California National Primate Research Center

NIH Pandemic-Era Grants

Pandemic Era Grants

2021

Document text

Principal Investigator: Prasant  Mohapatra
Organization: UNIVERSITY OF CALIFORNIA AT DAVIS
Fiscal Year: 2021
Award: $1,459,457
Funding agency: NIH Office of the Director

Revised Abstract:
The COVID-19 pandemic constitutes a significant challenge to health care systems in the United States and abroad. A systemic compromise of the organism following SARS-CoV-2 infection has emerged as an important factor associated with COVID-19 severity, disproportionally affecting older patients with comorbidities such as hypertension, diabetes, and dementia. In addition to respiratory symptoms, COVID-19 patients can present neurological symptoms, ranging from the frequent loss of smell to rare but severe neurovascular and neuroinflammatory events. These neurological symptoms disproportionally affect patients with Alzheimer’s disease (AD) and can potentially lead to clinical scenarios previously associated with faster neurodegenerative progression and worse behavioral outcomes. The involvement of the brain during COVID-19 and the mechanisms of interaction between SARS-CoV-2 and AD pathological routes, however, remain poorly understood. Our long-term goal in this project is to further our knowledge on how neuropathology may contribute to the complex clinical presentation of COVID-19 and how SARS-CoV-2 infection and AD can negatively synergize in vulnerable patients. The objective of this grant is to characterize the short-term effects of SARSCoV-2 in the brain during the acute stage of the infection in both young and aged diabetic animals, and a possible protective effect of immunotherapeutic prophylaxis. The central hypothesis is that SARS-CoV-2 is both neuroinvasive and neurotropic, accessing the brain and infecting neurons and potentially other cells within the CNS, leading to neurodegeneration, inflammation, and a brain environment conducive to dementia. The rationale is that other human coronaviruses are neuroinvasive and neurotropic, including the closely related SARS-CoV1, causing direct damage to neurons and myelin and triggering neuroinflammatory processes. Furthermore, the SARS-CoV-2 entry receptor ACE2 has been previously implicated in AD, and other coronavirus infections have been reported to trigger adaptive intracellular cascades linked to neurodegeneration. Our specific aims will test the following hypotheses: (Aim 1) SARS-CoV-2 is neuroinvasive, neurotropic, and its infection of brain cells causes neuronal and myelinic damage; (Aim 2) SARS-CoV-2 infection triggers neuroinflammation and cytokine release, and prophylactic treatment with immunotherapeutic agents, such as convalescent plasma and monoclonal antibodies, can affect the brain response; (Aim 3) COVID-19 and AD neuropathological routes interact directly at the molecular level through the regulation of ACE2 and stress response pathways. This contribution is significant as it will considerably advance our knowledge of COVID-19 pathology, opening new avenues of treatment and care for a major public health concern, while also providing the necessary framework to understand the long-term consequences of COVID-19 and its impact on AD pathology. The proposed research is innovative in its use of a highly translational non-human primate model to reveal the neurobiological aspects of viral infections.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><ACE2><AD dementia><AD pathology><Acute><Address><Affect><Age><Alzheimer><Alzheimer Type Dementia><Alzheimer disease><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's disease dementia><Alzheimer's disease pathology><Alzheimer's pathology><Alzheimers Dementia><Alzheimers disease><Amentia><Animals><Anosmia><Appointment><Area><Behavior><Biomedical Research><Brain><Brain Nervous System><COVID crisis><COVID disease severity><COVID epidemic><COVID infected patient><COVID pandemic><COVID patient><COVID positive patient><COVID severity><COVID-19><COVID-19 crisis><COVID-19 disease severity><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 infected patient><COVID-19 infection><COVID-19 pandemic><COVID-19 patient><COVID-19 positive patient><COVID-19 public health crisis><COVID-19 severity><COVID-19 virus><COVID19><COVID19 crisis><COVID19 disease severity><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 infection><COVID19 pandemic><COVID19 patient><COVID19 positive patient><COVID19 public health crisis><COVID19 severity><COVID19 virus><CV-19><CV19><California><Caring><Cell Body><Cells><Clinical><Clinical Treatment Moab><CoV-2><CoV2><Collaborations><Communicable Diseases><Communities><Complex><Core Facility><Coronaviridae Infections><Coronavirus Infections><Dementia><Development><Diabetes Mellitus><Disease><Disorder><Encephalon><Ensure><Environment><Event><Fostering><Funding><Funding Agency><Funding Source><Generalized Growth><Goals><Grant><Growth><HCoV><Health><Health Care Systems><Healthcare Systems><Human><Hypertension><Immunotherapeutic agent><Infection><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Inflammation><Infrastructure><Institution><Investigation><Investigators><Knowledge><Lead><Length of Life><Link><Longevity><Lung diseases><Medical><Mentors><Mission><Modeling><Modern Man><Molecular><Monoclonal Antibodies><Myelin><NIH><National Institutes of Health><Nerve Cells><Nerve Degeneration><Nerve Unit><Neural Cell><Neurobiology><Neurocyte><Neurologic Manifestations><Neurologic Signs and Symptoms><Neurologic Symptoms><Neurological Manifestations><Neurological Signs and Symptoms><Neuron Degeneration><Neurons><Neurosciences><Organism><Pathologic><Pathology><Pathway interactions><Patients><Pb element><Pilot Projects><Prevention><Primary Senile Degenerative Dementia><Primates><Primates Mammals><Process><Prophylactic treatment><Prophylaxis><Public Health><Pulmonary Diseases><Pulmonary Disorder><QOL><Quality of life><Receptor Protein><Regenerative Medicine><Regulation><Rejuvenation><Reporting><Reproductive Sciences><Research><Research Design><Research Personnel><Research Priority><Research Resources><Research Support><Research Training><Researchers><Resources><Respiratory Disease><Respiratory Signs and Symptoms><Respiratory System Disease><Respiratory System Disorder><Role><Route><SARS><SARS corona virus 2><SARS coronavirus disease><SARS-CoV disease><SARS-CoV-2><SARS-CoV-2 disease severity><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infected patient><SARS-CoV-2 infection><SARS-CoV-2 pandemic><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV-2 severity><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 infection><SARS-CoV2 pandemic><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Schools><Science><Scientist><Services><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome coronavirus disease><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Sight><Site><Study Type><Testing><Tissue Growth><Training><Translations><United States><United States National Institutes of Health><Universities><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Veterinarians><Viral Diseases><Virus Diseases><Vision><Wuhan coronavirus><ZIKA><aged><ages><airway symptom><angiotensin converting enzyme 2><angiotensin converting enzyme II><animal care><anosphrasia><base><behavior outcome><behavioral outcome><biological adaptation to stress><brain cell><career><co-morbid><co-morbidity><college><collegiate><comorbidity><convalescent plasma><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 disease severity><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 infected patient><coronavirus disease 2019 infection><coronavirus disease 2019 pandemic><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 public health crisis><coronavirus disease 2019 severity><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease infected patient><coronavirus disease pandemic><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease severity><coronavirus patient><cytokine><dementia of the Alzheimer type><design><designing><developmental><diabetes><diabetic><disease of the lung><disorder of the lung><elderly patient><enthusiastic atmosphere><enthusiastic environment><fighting><hCoV19><heavy metal Pb><heavy metal lead><high blood pressure><high standard><human CoV><human corona virus><human coronavirus><human disease><hyperpiesia><hyperpiesis><hypertensive disease><immune drugs><immune-based therapeutics><immunologic preparation><immunologic therapeutics><immunotherapeutics><immunotherapy agent><improved><industrial partnership><industry partner><industry partnership><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><innovate><innovation><innovative><life span><lifespan><living system><loss of smell><lung disorder><mAbs><nCoV2><neural degeneration><neural manifestation><neuro-vascular><neurobiological><neurodegeneration><neurodegenerative><neuroinflammation><neuroinflammatory><neurological degeneration><neuronal><neuronal degeneration><neuropathology><neurotropic><neurovascular><next generation><non-human primate><nonhuman primate><older patient><olfactory loss><ontogeny><pathway><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><pilot study><primary degenerative dementia><programs><protective effect><psychologic><psychological><public-private partnership><pulmonary symptom><reaction; crisis><receptor><recruit><respiratory symptom><response><responsible research conduct><senile dementia of the Alzheimer type><severe acute respiratory syndrome coronavirus 2 disease severity><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><severe acute respiratory syndrome coronavirus 2 severity><social role><stress response><stress; reaction><study design><success><supportive atmosphere><supportive environment><translational impact><translational investigator><translational researcher><translational scientist><viral infection><virus infection><virus-induced disease><visual function>